Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abemaciclib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06650423
What this trial is testing

Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

Who this might be right for
Early Breast CancerHormone Receptor Positive TumorHER2-negative Breast Cancer
Institute of Oncology Ljubljana 319
Early research (Phase 1)Study completedNCT04627064
What this trial is testing

ABEMA Alone or in COMBO With MK-6482

Who this might be right for
Clear Cell Renal Cell Carcinoma
Dana-Farber Cancer Institute 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784
What this trial is testing

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more
University of Washington 20
Not applicableNot Yet RecruitingNCT07817212
What this trial is testing

ESR1Real World Assessment Prevalence Study

Who this might be right for
HR+/HER2- aBC Undergoing 1L Treatment With CDK4/6i (Palbociclib, Abemaciclib or Ribociclib) and AI (Anastrozole or Letrozole)
Institut fuer Frauengesundheit 1,550
Large-scale testing (Phase 3)Active Not RecruitingNCT02246621
What this trial is testing

Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Eli Lilly and Company 493
Testing effectiveness (Phase 2)Looking for participantsNCT06062498
What this trial is testing

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

Who this might be right for
Estrogen-receptor-positive Breast CancerHER2/Neu-Negative Breast CancerAdvanced Breast Cancerv+1 more
Northwestern University 174
Early research (Phase 1)Study completedNCT04514159
What this trial is testing

ZN-c5 and Abemaciclib in Participants With Breast Cancer

Who this might be right for
Breast Cancer
Zeno Alpha Inc. 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04616183
What this trial is testing

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+28 more
M.D. Anderson Cancer Center 46
Not applicableNot Yet RecruitingNCT07406594
What this trial is testing

Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer

Who this might be right for
Breast CancerHER-2 Positive Breast Cancer
University of Vermont Medical Center 12
Testing effectiveness (Phase 2)Ended earlyNCT04298983
What this trial is testing

Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of Alabama at Birmingham 9
Early research (Phase 1)WithdrawnNCT04316169
What this trial is testing

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Who this might be right for
Solid TumorAdvanced Breast Cancer
Medical College of Wisconsin
Testing effectiveness (Phase 2)Looking for participantsNCT05774899
What this trial is testing

CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC

Who this might be right for
Adenoid Cystic CarcinomaMetastatic Adenoid Cystic CarcinomaRecurrent Adenoid Cystic Carcinoma
Michael J. Dennis, MD 32
Testing effectiveness (Phase 2)Ended earlyNCT04003896
What this trial is testing

Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Milton S. Hershey Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT02441946
What this trial is testing

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

Who this might be right for
Breast CancerHormone Receptor Positive TumorEarly-Stage Breast Carcinoma
Eli Lilly and Company 224
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07832227
What this trial is testing

Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial

Who this might be right for
Low Grade Ovarian Serous AdenocarcinomaEndometrial Cancer
Dana-Farber Cancer Institute 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03220646
What this trial is testing

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Who this might be right for
Brain Tumor
Memorial Sloan Kettering Cancer Center 64
Very early researchStudy completedNCT04391595
What this trial is testing

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

Who this might be right for
GlioblastomaGBMGlioma
Nader Sanai 42
Testing effectiveness (Phase 2)Study completedNCT04751929
What this trial is testing

Abemaciclib With or Without Atezolizumab for mCRPC

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 19
Large-scale testing (Phase 3)Looking for participantsNCT06341621
What this trial is testing

Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib

Who this might be right for
Breast Cancer
Fudan University 1,900
Not applicableLooking for participantsNCT07407439
What this trial is testing

Real-world Studies of CDK4/6 Inhibitors

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 245
Next Page